4th Quarter - Report

NATIONAL ASSOCIATION OF CHAIN DRUG STORES for NATIONAL ASSOCIATION OF CHAIN DRUG STORES

Firm
Client
Income
—
Expenses
$380,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

H.R.1735 - National Defense Authorization Act for Fiscal Year 2016 S. 1118 National Defense Authorization Act for Fiscal Year 2016

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
HEIDI ANN ECKER —
ANNE FOLEY —
YVONNE HAMPEL —
AMBER MANKO New —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —
WILLIAM TIGHE New Rep. Tom Marino

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Drug Enforcement Administration (DEA); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1735 (114th), S. 1118 (114th)

Pharmacy PHA

H.R.5194 - 114th Congress (2015-2016)Safe Drug Disposal Tax Credit Act of 2016 H.R. 2841 the FAST Generics Act of 2015. S.3056: CREATES Act of 2016.

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
HEIDI ANN ECKER —
ANNE FOLEY —
YVONNE HAMPEL —
AMBER MANKO New —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —
WILLIAM TIGHE New Rep. Tom Marino

Contacted: Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Bills named: S. 3056 (114th), H.R. 2841 (114th), H.R. 5194 (114th)

Alcohol and Drug Abuse ALC

H.R. 471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.524 - Comprehensive Addiction and Recovery Act of 2016 H.R.953 - Comprehensive Addiction and Recovery Act of 2015 HR 3250 - DXM Abuse Prevention Act S. 2294 - DXM Abuse Prevention Act H.R. 5046 - Comprehensive Opioid Abuse Reduction Act of 2016 H.R.4931 - Pharmaceutical Stewardship Act of 2016 S. 3075 - Addiction Prevention and Responsible Opioid Practices Act

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
HEIDI ANN ECKER —
ANNE FOLEY —
YVONNE HAMPEL —
AMBER MANKO New —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —
WILLIAM TIGHE New Rep. Tom Marino

Contacted: Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 953 (114th), H.R. 5046 (114th), S. 524 (114th), H.R. 471 (114th), H.R. 4931 (114th), S. 483 (114th), S. 3075 (114th), S. 2294 (114th), H.R. 3250 (114th)

Medicare/Medicaid MMM

S. 314 - Pharmacy and Medically Underserved Areas Enhancement Act H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act H.R. 1270 - Restoring Access to Medication Act of 2015 S. 709 - Restoring Access to Medication Act of 2015 S.776 - Medication Therapy Management Empowerment Act of 2015 H.R. 793 - Ensuring Seniors Access to Pharmacies Act of 2015 H.R. 1021, the Protecting the Integrity of Medicare Act (PIMA) of 2015 H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R.6 - 21st Century Cures Act S.1190 - Ensuring Seniors Access to Local Pharmacies Act of 2015 S. 1913 - Stopping Medication Abuse and Protecting Seniors Act of 2015 H.R.4878 - Better Care, Lower Cost Act S. 3094 - Price Relief, Innovation, and Competition for Essential Drugs Act HR 5573 - Price Relief, Innovation and Competition for Essential Drugs Act H. R. 4641 -To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes. HR 5210-Patient Access to Durable Medical Equipment Act S 2736-Patient Access to Durable Medical Equipment Act of 2016 H.R. 1192 - National Diabetes Clinical Care Commission Act S. 3056 - Creating and Restoring Equal Access to Equivalent Samples Act H.R. 5951- Improving Transparency and Accuracy in Medicare Part B Spending

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
HEIDI ANN ECKER —
ANNE FOLEY —
YVONNE HAMPEL —
AMBER MANKO New —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —
WILLIAM TIGHE New Rep. Tom Marino

Contacted: Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD)

Bills named: H.R. 4878 (114th), H.R. 5573 (114th), H.R. 1021 (114th), H.R. 4641 (114th), S. 1190 (114th), H.R. 5210 (114th), H.R. 2 (114th), H.R. 1192 (114th), S. 776 (114th), H.R. 5951 (114th), H.R. 6 (114th), H.R. 793 (114th), S. 1913 (114th), H.R. 592 (114th), S. 3056 (114th), S. 709 (114th), S. 3094 (114th), H.R. 1270 (114th), S. 314 (114th)

Budget/Appropriations BUD

H.R. 83: Consolidated and Further Continuing Appropriations Act, 2015 FY2017 Senate Budget Resolution (S. Con. Res. 3)

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
HEIDI ANN ECKER —
ANNE FOLEY —
YVONNE HAMPEL —
AMBER MANKO New —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —
WILLIAM TIGHE New Rep. Tom Marino

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Defense, Dept of (DOD); Drug Enforcement Administration (DEA)

Bills named: H.R. 83 (114th), S.Con.Res. 3 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.